A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: The significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis

References

• Yang Y, Forslund A, Remotti H, Lönnroth C, Andersson M, Brevinge H, p53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection. Cancer 2001;91:727–36.
   PubMed Web of Science ®Google Scholar
• De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53 and Ki67 in colorectal liver metastases and corresponding primary tumor. Hepatology 1998;28:971–9.
   PubMed Web of Science ®Google Scholar
• Nitti D, Belluco C, Montesco MC, Bertorelle R, Da Pian PP, Fassina A, Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival. Eur J Cancer 1998;34:851–5.
   PubMed Web of Science ®Google Scholar
• Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: A review. J Surg Oncol 2006;94:68–80.
   PubMed Web of Science ®Google Scholar
• Rudmik LR, Magliocco AM. Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol 2005;92:347–59.
   PubMedGoogle Scholar
• Neal CP, Garcea G, Doucas H, Manson MM, Sutton CD, Dennison AR, Molecular prognostic markers in resectable colorectal liver metastases: a systematic review. Eur J Cancer 2006;42:1728–43.
   PubMed Web of Science ®Google Scholar
• Jessup JM, Petrick AT, Toth CA, Ford R, Meterissian S, O'Hara CJ, Carcinoembryonic antigen: Enhancement of liver colonisation through retention of human colorectal carcinoma cells. Br J Cancer 1993;67:464–70.
   PubMed Web of Science ®Google Scholar
• Gangopadhyay A, Lazure DA, Thomas P. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 1998;16:703–12.
   PubMed Web of Science ®Google Scholar
• Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58–61.
   PubMed Web of Science ®Google Scholar
• Witton CJ, Hawe SJ, Cooke TG, Bartlett JM. Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology 2004;45:47–54.
   PubMed Web of Science ®Google Scholar
• Carrasco JL, Jover L. Estimating the generalized concordance correlation coefficient through variance components. Biometrics 2003;59:849–58.
   PubMed Web of Science ®Google Scholar
• Kirkegaard T, Edwards J, Tovey S, McGlynn LM, Krishna SN, Mukherjee R, Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology 2006;48:787–94.
   PubMed Web of Science ®Google Scholar
• Adachi Y, Inomata M, Kakisako K, Sato K, Shiraishi N, Kitano S, Histopathologic characteristics of colorectal cancer with liver metastasis. Dis Colon Rectum 1999;42:1053–6.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003;39:718–27.
   PubMed Web of Science ®Google Scholar
• Carriquiry LA, Pineyro A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum 1999;42:921–9.
   PubMed Web of Science ®Google Scholar
• Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I, Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 2000;13:925–33.
   PubMed Web of Science ®Google Scholar
• Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309–18.
   PubMed Web of Science ®Google Scholar
• Park JK, Kim NK, Lee KY, Lee WJ, Kim BR, Sohn SK, Prognostic factors affecting survival rate following hepatic resection for metastatic colorectal cancer. J Korean Surg Soc 2001;61:583–7.
   Google Scholar
• Jenkins LT, Milikan KW, Bines SD, Staren ED, Doolas A. Hepatic resection for metastatic colorectal cancer. Am Surg 1997;63:605–10.
   PubMed Web of Science ®Google Scholar
• Jessup JM, Ishii S, Mitzoi T, Edmiston KH, Shoji Y. Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells. Clin Exp Metastasis 1999;17:481–8.
   PubMed Web of Science ®Google Scholar
• Thomas P, Toth Ca, Saini KS, Jessup JM, Steele G. The structure metabolism and function of the carcinoembryonic antigen gene family. Biochim Biophys Acta 1990;1032:177–89.
   PubMedGoogle Scholar
• Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin 1. J Cell Sci 2000;114:111–8.
   Web of Science ®Google Scholar
• Murray GI, Duncan ME, O'Neil P, Melvint WT, Fothergill JE, Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461–2.
   PubMed Web of Science ®Google Scholar
• Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 2000;5:108–14.
   PubMedGoogle Scholar
• Oberg A, Hoyhtya M, Tavelin B, Stenling R, Lindmark G. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res 2000;20:1085–91.
   PubMed Web of Science ®Google Scholar
• Waas ET, Wobbes T, Ruers T, Lomme RM, Hendriks T. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease. Eur J Surg Oncol 2006;32:756–63.
   PubMed Web of Science ®Google Scholar
• Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993;71:4252–66.
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl Med 1971;285:1182–6.
   PubMed Web of Science ®Google Scholar
• Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis, and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368–80.
   PubMed Web of Science ®Google Scholar
• Nigel CB, David M, Ali WM. Biology of colorectal liver metastases: A Review. J Surg Oncol 2006;94:68–80.
   PubMed Web of Science ®Google Scholar
• Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993;157:351–8.
   PubMed Web of Science ®Google Scholar
• Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993;156:235–46.
   PubMed Web of Science ®Google Scholar
• Pozzi A, LeVine WF, Gardner HA. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis. Oncogene 2002;21:272–81.
   PubMed Web of Science ®Google Scholar